Loading ...Advice to Practitioners 
Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection(Comments Off)
MEDICAL PROGRESS Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza Illness caused by the 2009 H1N1 virus has occurred in almost all countries, with more than 16,000 deaths from laboratory-confirmed cases reported to the WHO. This review by WHO [...]
Certain H1N1 Vaccines Should Be Given by Feb. 15
All lots of Sanofi Pasteur H1N1 vaccine in prefilled syringes should be administered by February 15 because of concerns over reduced potency, the CDC reported on Wednesday.
Three Studies Demonstrate the Safety and Efficacy of Pandemic H1N1 Flu Vaccine
Results are in from studies in the U.S., China, and Hungary. (more…)
Case 40-2009 — A 29-Year-Old Man with Fever and Respiratory Failure
CASE RECORDS OF THE MASSACHUSETTS GENERAL HOSPITAL Case 40-2009 — A 29-Year-Old Man with Fever and Respiratory Failure T.M. Uyeki, A. Sharma, and J.A. Branda A 29-year-old man presented with fever and respiratory distress. He had fever, a nonproductive cough, and myalgias. On admission to this hospital, he was hypoxemic. Respiratory failure, renal failure, and [...]
More in this category
- Some Intranasal H1N1 Vaccine Recalled over Potency Concerns
- One Dose of H1N1 Vaccine May Be Enough for Children
- Neuraminidase Inhibitors Have Only ‘Modest Effectiveness’ in Otherwise Healthy Adults with Flu
- H1N1 Vaccine Safety ‘Reassuring’
- ECMO for Patients with 2009 H1N1 Influenza and ARDS
- Estimates of Flu’s Toll; Seasonal Vaccine Not Effective Against 2009 H1N1
